zika
viru
zikv
outbreak
start
year
consid
fastest
wide
spread
outbreak
report
flaviviru
polymeras
domain
protein
target
viral
infect
recogn
suitabl
target
zikv
infect
differ
novel
modifi
compound
zikv
test
silico
structur
solv
zikv
polymeras
deposit
protein
data
bank
websit
two
solv
structur
resolut
less
use
studi
test
bind
novel
compound
silico
molecular
dock
use
quantifi
bind
affin
zikv
polymeras
compar
hepat
c
viru
total
novel
compound
reveal
result
either
similar
better
physiolog
molecul
guanosin
triphosph
water
molecul
found
facilit
bind
compound
zikv
rnadepend
rna
polymeras
rdrp
structur
present
novel
compound
repres
good
binder
zikv
rdrp
could
suitabl
candid
develop
new
effect
antizikv
polymeras
nucleotid
inhibitor
k
e
w
r
drugprotein
interact
guanosin
deriv
molecular
dock
rnadepend
rna
polymeras
zika
viru
seventi
year
ago
uganda
zika
viru
zikv
report
first
time
six
decad
later
newer
incid
emerg
record
nigeria
seneg
gabon
despit
spread
report
zikv
infect
like
latest
emerg
outbreak
year
latin
america
zikv
transmit
bodi
fluid
sexual
direct
link
newborn
microcephali
pregnant
women
infect
confirm
year
mosquito
bite
main
rout
spread
zikv
infect
along
sexual
intercours
mild
symptomat
zikv
infect
easili
detect
bodi
fluid
like
blood
urin
saliva
sever
neurolog
diseas
steril
report
patient
viru
target
cell
nervou
system
zikv
genom
singlestrand
rna
encod
amino
acid
polyprotein
process
viral
host
proteas
ten
function
protein
nonstructur
protein
wide
conserv
protein
target
previou
viral
infect
like
hepat
c
viru
hcv
zikv
rnadepend
rna
polymeras
rdrp
domain
protein
target
antihcv
drug
repurpos
nucleotid
inhibitor
mimic
nativ
nucleotid
abil
select
target
activ
site
ad
primer
rna
strand
bound
protein
nucleotid
inhibitor
block
polymer
process
caus
protein
inhibit
guanosin
deriv
studi
hcv
polymeras
candid
clinic
trial
phase
iib
halt
due
side
effect
year
gave
better
result
compar
uridin
deriv
sofosbuvir
adenin
deriv
widerang
antivir
ribavirin
hcv
human
coronavirus
silico
molecular
model
repres
success
method
use
predict
drugtarget
bind
potenc
mode
interact
base
suitabl
model
differenti
activ
inact
inhibitor
suggest
new
compound
silico
screen
solv
structur
deposit
protein
data
bank
recent
zikv
protein
studi
author
use
two
structur
pdb
code
drug
target
due
appropri
resolut
respect
compar
solv
structur
zikv
autodock
vina
use
dock
calcul
method
crossdock
hcv
rdrp
seventyfour
new
compound
test
studi
zikv
rdrp
structur
compound
deriv
guanin
nucleotid
structur
ligand
prepar
use
scigress
tool
modif
base
previou
work
three
group
modif
introduc
posit
ribos
ring
guanosin
deriv
structur
geometri
optim
perform
use
follow
scheme
classic
mechan
geometri
optim
forc
field
follow
semiempir
parameter
method
final
quantum
mechan
densiti
function
theori
use
function
calcul
perform
ghz
intel
processor
pc
gb
ram
use
scigress
softwar
target
retriev
prepar
dock
seventyfour
modifi
guanosin
deriv
see
tabl
sketch
optim
use
procedur
elfiki
modifi
compound
base
modifi
ribos
ring
guanosin
triphosph
gtp
addit
bulki
group
posit
gave
good
result
hcv
rdrp
previou
studi
autodock
vina
implement
scigress
softwar
use
studi
calcul
bind
energi
ligand
target
polymeras
zikv
hcv
figur
interact
amino
acid
ligand
also
list
tabl
number
water
molecul
take
part
interact
water
molecul
mediat
interact
bind
ligand
protein
bind
pocket
suggest
potent
inhibitor
zikv
rdrp
primari
goal
studi
figur
show
almost
compound
good
bind
energi
zikv
polymeras
compar
hcv
rdrp
group
iii
modif
dock
score
zikv
almost
rang
hcv
except
compound
group
iii
bit
higher
dock
score
valu
tabl
impli
effect
modifi
compound
compet
activ
site
zikv
polymeras
rdrp
suggest
suitabl
target
hcv
virus
due
vital
role
replic
viru
due
conserv
rdrp
activ
site
also
target
zikv
viral
infect
previou
studi
show
antihcv
drug
abl
bind
zikv
rdrp
repurpos
trial
rel
lower
affin
compar
hcv
studi
author
present
modifi
guanosin
deriv
show
silico
effect
zikv
rdrp
experiment
work
suggest
character
modif
appli
viru
vitro
vivo
assay
